Free Trial

HEALTHCARE: Abbott Labs (ABT: Aa3/AA-): Patent Agreement

HEALTHCARE

Positive - Abbott Labs and DexCom have agreed to dismiss all pending patent disputes.

  • No financial settlement
  • Have agreed not to sue each other for next 10 years
  • Abbott has performed steadily recently but well off its glory days of 2010-2021.
  • The credit has gone from Baa3 in 2017 to Aa3 now. Little upside but good to see a risk removed.

Press Release Link

59 words

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.

Positive - Abbott Labs and DexCom have agreed to dismiss all pending patent disputes.

  • No financial settlement
  • Have agreed not to sue each other for next 10 years
  • Abbott has performed steadily recently but well off its glory days of 2010-2021.
  • The credit has gone from Baa3 in 2017 to Aa3 now. Little upside but good to see a risk removed.

Press Release Link